1. Home
  2. VATE vs ACET Comparison

VATE vs ACET Comparison

Compare VATE & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VATE
  • ACET
  • Stock Information
  • Founded
  • VATE 1994
  • ACET 1947
  • Country
  • VATE United States
  • ACET United States
  • Employees
  • VATE N/A
  • ACET N/A
  • Industry
  • VATE Metal Fabrications
  • ACET Biotechnology: Pharmaceutical Preparations
  • Sector
  • VATE Industrials
  • ACET Health Care
  • Exchange
  • VATE Nasdaq
  • ACET Nasdaq
  • Market Cap
  • VATE 62.0M
  • ACET 69.9M
  • IPO Year
  • VATE 1996
  • ACET N/A
  • Fundamental
  • Price
  • VATE $4.32
  • ACET $0.81
  • Analyst Decision
  • VATE
  • ACET Buy
  • Analyst Count
  • VATE 0
  • ACET 4
  • Target Price
  • VATE N/A
  • ACET $5.50
  • AVG Volume (30 Days)
  • VATE 43.4K
  • ACET 1.7M
  • Earning Date
  • VATE 11-05-2025
  • ACET 11-05-2025
  • Dividend Yield
  • VATE N/A
  • ACET N/A
  • EPS Growth
  • VATE N/A
  • ACET N/A
  • EPS
  • VATE N/A
  • ACET N/A
  • Revenue
  • VATE $995,000,000.00
  • ACET N/A
  • Revenue This Year
  • VATE N/A
  • ACET N/A
  • Revenue Next Year
  • VATE N/A
  • ACET N/A
  • P/E Ratio
  • VATE N/A
  • ACET N/A
  • Revenue Growth
  • VATE N/A
  • ACET N/A
  • 52 Week Low
  • VATE $3.35
  • ACET $0.45
  • 52 Week High
  • VATE $13.79
  • ACET $1.54
  • Technical
  • Relative Strength Index (RSI)
  • VATE 39.51
  • ACET 49.83
  • Support Level
  • VATE $4.53
  • ACET $0.79
  • Resistance Level
  • VATE $4.80
  • ACET $1.03
  • Average True Range (ATR)
  • VATE 0.33
  • ACET 0.06
  • MACD
  • VATE -0.04
  • ACET 0.00
  • Stochastic Oscillator
  • VATE 8.60
  • ACET 18.11

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: